DUDLEY ROBERT MICHAEL (Chief Executive Officer) purchased 3.6% of their position (30K shares) of TRANSCODE THERAPEUTICS, INC. on the open market
Open‑market purchase worth $55.4K — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 6/1/2022ACC: 0001104659-22-067099
DirectorOfficer10% Owner· Chief Executive Officer
Since Jul 2021
+30K
Net shares
Net buyer
$55.4K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
30K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+28K
Price / share
$1.84
Trade value
$51.64K
% of position
3.3%
5/27/2022
843.11K→871.11K
Common Stock
Direct
Shares
+2K
Price / share
$1.87
Trade value
$3.74K
% of position
0.2%
5/31/2022
871.11K→873.11K
Total
Net shares
+30K
Net value
$55.38K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/27/2022 | P · Purchase | +28K | $1.84 | $51.64K | 3.3% | 843.11K | 871.11K |
| Common Stock Direct | 5/31/2022 | P · Purchase | +2K | $1.87 | $3.74K | 0.2% | 871.11K | 873.11K |
| Total | +30K | $55.38K | ||||||
Derivative Transactions0
No derivative transactions reported